Philip Wong

Philip Wong

Interventional cardiologist / Cardiologist
National Heart Center Singapore - Singapore, Singapore

1. Clinician Innovator and interventional cardiologist with greater than 25 years of clinical experience and over 3000 cases performed as a primary operator of percutaneous coronary intervention.
Dr Wong has attended to greater than 20,000 outpatient visits over this period.

2. Experienced in pre-clinical research & development of medical devices, including class III/IV implantable devices.

3. Deputy Director, National Heart Center Research Institute Singapore, a newly formed stand alone research entity of the National Heart Center, comprising a 40,000 sq foot state of art basic research facility, Bio-banking and stem cell facility with 30+ research staff, focusing on Induced Pluripotent Stem Cell research and small experimental model imaging in the cardiovascular arena.
This facility incorporates a full suite GMP facility for cell processing on suite to the cardiac labs and operating theaters.
Dr Wong conceptualized and planned the NHRIS facility. Prior to this, Dr Wong led the Research & Development Unit of the NHCS since 2003.

4. A*STAR Program Leader, Cardiovascular Devices.

5. Assoc. Professor, Duke-NUS Graduate Medical School, Singapore.

6. Adjunct Professor, School of materials science and engineering, Nanyang Technological University, Singapore.

7. Founder & Chief Executive Officer/ Chief Technical Officer: Innoheart Pte Ltd; 12,000 sq foot Preclinical Contract Research Organization for evaluation of implantable medical devices.
Dr Wong has been Study PI in over 70 small and large animal studies, including several GLP studies used for regulatory approvals.

8. Founder & Medical Director, WEB Biotechnologies Pte Ltd. WEB produces the Spyder ECG solution, the world’s first Cloud - Based continuous remote ECG monitor. www.web-biotech.com

Latest contributions

Forty years of interventional innovation: what is the next big thing?

15 May 2017 – From PCR Innovators Day Paris 2017

Chien Foundation Fellows Session

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Richard NG

Chairperson

Richard Ng
Philip Wong

Chairperson

Philip Wong

Acute myocardial infarction

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Philip Wong

Chairperson

Philip Wong

Making complex simple with advance technology

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Masahiko Ochiai

Chairperson

Masahiko Ochiai

New and Emerging Coronary Scaffolds

21 Jan 2016 – From AsiaPCR/SingLIVE 2016

Alexandre Abizaid

Chairperson

Alexandre Abizaid
Philip Wong

Chairperson

Philip Wong

LIVE case: complex left main disease

From ASIAPCR/SINGLIVE 2016

Watch this LIVE case if you want to learn more about complex left main disease.

A 61-year old with left main (LM) bifurcation and mid-LAD disease:

IVUS evaluation for sizing and optimisation of stent implantationCrush strategy
Prof. Tian-Hai Koh

Operator

Tian Hai Koh
Philip Wong

Operator

Philip Wong

Complex left main disease

From ASIAPCR/SINGLIVE 2016

Facilitators: E. Eeckhout and U. Kaul

Watch this LIVE session if you want to learn more about complex coronary interventions.

A 61-year old with left main (LM) bifurcation and mid-LAD disease:

IVUS evaluation for sizing and optimisation of stent implantationCrush strategy
Prof. Tian-Hai Koh

Operator

Tian Hai Koh
Philip Wong

Operator

Philip Wong

Abbott Vascular Innovations and Preview of Next-Gen Absorb

21 Jan 2016 – From AsiaPCR/SingLIVE 2016

Complications management

23 Jan 2013 – From AsiaPCR/SingLIVE 2013

Philip Wong

Chairperson

Philip Wong
Upendra Kaul

Chairperson

Upendra Kaul